Abstract
Premenopausal women are at increased risk for numerous pain disorders. Although this sex difference is far from understood, many studies have shown the importance of estrogen in the enhancement of nociceptive signaling. Estrogen receptors (ERs) are present on sensory neurons, and we have previously shown that 17β‐estradiol (E2) rapidly enhances signaling of the inflammatory mediator, bradykinin (BK), in vitro and in vivo. The aim of this study was to further characterize and delineate mechanisms involved in the enhancement of BK signaling by E2. Pretreatment (15 min) with the ERα‐selective agonist, PPT, significantly enhanced BK‐induced PLC activity in cultures of primary sensory neurons and thermal allodynia. The ERβ‐selective agonist, DPN, and the GPR30‐selective agonist, G‐1, had no effect. Enhancement of BK signaling by E2 was seen with pretreatment times ranging from 0 (co‐injection) to 60 min, and persisted for up to 60 min following washout of E2. The effect of E2 was not blocked by the transcription inhibitor anisomycin and was mimicked by E2 conjugated to BSA (membrane impermeable). These data suggest that ERα mediates the rapid onset effect of E2 to enhance BK signaling and that the effect of E2 is non‐genomic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.